Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Comment by SlangEditor00on Oct 26, 2020 12:24pm
83 Views
Post# 31781748

RE:RE:RE:"Class, who's at the front here?"

RE:RE:RE:"Class, who's at the front here?"1. They signed a distribution agreement with Shoppers. Delay, no delay, it is a good thing. No matter what youe imagination dreams up. If you spoke with IR you would have the answer as to why already. Covid affected production, like many other companies. Not to mention they had to pivot to try and help people dying from heart diease when diagnosed with covid. If you stopped listening to yourself type all day, you could probably figure out most of this on by yourself!! Imagine that.

2. Why in gods name would you try and compete with a monster like Dalton. I shouldn't even have to explain why partening with them is the right move! Give me a break man. It's not even a serious thought. Wake up. Pull the keyboard out of your ....

3. The comment about who would buy this. You can't be serious. I guess you must not have kids.
Nothing you have said today should be taken seriously by anyone.

4. Biovectera - give me a break. Enough said. That's a joke.

Awaiting response. You too maple leaf - truth hurts. Get real man.,




<< Previous
Bullboard Posts
Next >>